T2	intervention 56 67	fenretinide
T3	total-participants 494 498	1739
T4	age 505 515	aged 30-70
T5	intervention-participants 517 520	872
T6	control-participants 548 551	867
T7	control 559 570	observation
T9	outcome 727 758	number of second breast cancers
T10	iv-bin-abs 763 766	168
T11	cv-bin-abs 794 797	190
T12	iv-bin-abs 870 872	83
T13	cv-bin-abs 907 910	126
T16	iv-bin-abs 993 995	85
T17	cv-bin-abs 1000 1002	64
T1	outcome-Measure 662 721	second primary breast cancer (contralateral or ipsilateral)
T8	outcome 1306 1329	cancers in other organs
T18	outcome 1331 1349	distant metastases
T19	outcome 1353 1361	survival
T20	outcome 873 879	events
